Xometry, Inc. (XMTR) Key Metrics
XMTR valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.21B
- Enterprise value
- $5.84B
- P/E (TTM)
- —
- Forward P/E
- 94.3
- PEG ratio
- —
- Price / sales
- 6.5 10-yr median 4.0
- Price / book
- 10.1 10-yr median 5.6
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.23
XMTR key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsXMTR valuation Price multiples at each fiscal year-end price.
XMTR returns How much profit the business earns on the capital it uses.
XMTR per-share figures Results divided by the shares outstanding at year-end.
XMTR financial health Debt, liquidity and how easily interest is covered.
XMTR efficiency & capital use Working capital cycle and where the cash goes.
XMTR valuation history
XMTR returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
XMTR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
XMTR cash returned to shareholders
XMTR price vs earnings per share
XMTR key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $3.02B | $2.09B | $1.72B | $1.52B | $2.39B | — | — |
| Enterprise value | $3.15B | $2.15B | $1.75B | $1.50B | $2.30B | — | — |
| Price / sales | 4.4 | 3.8 | 3.7 | 4.0 | 11.0 | — | — |
| Price / book | 11.0 | 6.7 | 5.2 | 4.1 | 5.6 | — | — |
| Price / operating cash flow | 496.5 | — | — | — | — | — | — |
| EV / sales | 4.6 | 3.9 | 3.8 | 3.9 | 10.5 | — | — |
| Earnings yield | −2.0% | −2.4% | −3.9% | −5.2% | −2.6% | — | — |
| Free cash flow yield | −0.8% | −1.6% | −2.8% | −5.0% | −3.1% | — | — |
| Dividend yield | — | — | — | 0.0% | 0.0% | — | — |
| Shareholder yield (dividends + buybacks) | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Share price at fiscal year-end | $59.47 | $42.66 | $35.91 | $32.23 | $51.25 | — | — |
| Per share | |||||||
| Revenue per share | $13.51 | $11.11 | $9.67 | $8.08 | $4.68 | $3.19 | $1.81 |
| Earnings per share | −$1.22 | −$1.03 | −$1.41 | −$1.68 | −$1.32 | −$0.70 | −$0.70 |
| Operating cash flow per share | $0.12 | −$0.31 | −$0.62 | −$1.33 | −$1.47 | −$0.50 | −$0.61 |
| Free cash flow per share | −$0.47 | −$0.68 | −$1.01 | −$1.62 | −$1.60 | −$0.59 | −$0.67 |
| Cash per share | $4.31 | $4.89 | $5.61 | $6.77 | $2.50 | $1.35 | $1.15 |
| Book value per share | $5.42 | $6.41 | $6.87 | $7.86 | $9.09 | −$2.51 | −$1.65 |
| Tangible book value per share | −$0.33 | $0.40 | $0.64 | $1.55 | $2.74 | −$2.57 | −$1.76 |
| Dividends per share | — | — | — | $0.00 | $0.00 | $0.20 | $0.20 |
| Capex per share | $0.59 | $0.37 | $0.39 | $0.29 | $0.13 | $0.09 | $0.06 |
| Debt per share | $6.87 | $6.01 | $6.25 | $6.41 | $0.48 | $0.40 | $0.33 |
| Shares outstanding | 50.8M | 49.1M | 47.9M | 47.2M | 46.7M | 44.3M | 44.3M |
| Change in shares outstanding | +3.5% | +2.4% | +1.6% | +1.0% | +5.3% | 0.0% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | −20.9% | −15.7% | −19.3% | −19.9% | −39.2% | — | — |
| Return on invested capital (ROIC) | −9.3% | −12.2% | −16.3% | −17.8% | −52.4% | — | — |
| Return on assets (ROA) | −8.9% | −7.3% | −9.4% | −12.8% | −20.8% | −37.4% | −40.0% |
| Return on tangible assets | −15.0% | −13.1% | −16.5% | −18.1% | −29.8% | −36.0% | −42.7% |
| Free cash flow margin | −3.5% | −6.1% | −10.4% | −20.0% | −34.3% | −18.6% | −37.2% |
| Financial health | |||||||
| Total debt | $349.3M | $295.1M | $299.5M | $302.3M | $22.5M | $17.9M | $14.6M |
| Cash & short-term investments | $219.1M | $239.8M | $268.8M | $319.4M | $116.7M | $59.9M | $51.0M |
| Net debt | $130.1M | $55.3M | $30.7M | −$17.1M | −$94.3M | −$42.0M | −$36.4M |
| Debt / equity | 1.27 | 0.94 | 0.91 | 0.82 | 0.05 | — | — |
| Debt / assets | 0.50 | 0.43 | 0.42 | 0.41 | 0.04 | 0.20 | 0.19 |
| Current ratio | 3.76 | 4.38 | 4.28 | 6.05 | 2.87 | 2.02 | 4.13 |
| Quick ratio | 3.72 | 4.33 | 4.25 | 6.02 | 2.83 | 1.96 | 4.04 |
| Interest coverage | -9.3 | -11.8 | -15.4 | -17.4 | -68.9 | -26.8 | -126.8 |
| Working capital | $245.7M | $252.8M | $273.0M | $323.2M | $106.4M | $39.3M | $49.6M |
| Invested capital | $405.7M | $369.8M | $360.0M | $353.6M | $330.2M | −$153.2M | −$109.5M |
| Tangible asset value | −$15.6M | $20.8M | $31.7M | $74.4M | $129.1M | −$113.9M | −$77.9M |
| Net current asset value | −$92.3M | −$37.0M | −$20.7M | $24.9M | $86.3M | −$122.6M | −$85.1M |
| Graham net-net per share | −$2.61 | −$1.37 | −$1.13 | −$0.11 | $1.39 | −$2.89 | −$2.02 |
| Capital allocation | |||||||
| Dividends paid | — | — | — | $0 | $0 | $8.8M | $8.8M |
| Share buybacks (net) | $8.1M | $0 | $0 | $0 | $0 | $12.9M | $0 |
| Capex / revenue | 4.4% | 3.3% | 4.0% | 3.6% | 2.9% | 3.0% | 3.4% |
| Capex / operating cash flow | 495.9% | — | — | — | — | — | — |
| Capex / depreciation | 1.61 | 1.39 | 1.72 | 1.75 | 1.74 | 1.34 | 1.46 |
| Stock-based compensation / revenue | 5.3% | 5.4% | 4.8% | 5.0% | 3.4% | 0.7% | 0.7% |
| R&D / revenue | 6.8% | 7.2% | 7.4% | 8.1% | 8.1% | 8.6% | 13.3% |
| SG&A / revenue | 28.4% | 31.8% | 35.5% | 37.4% | 34.1% | 24.5% | 28.2% |
| Efficiency | |||||||
| Days sales outstanding | 45.5 | 48.2 | 47.0 | 39.1 | 39.3 | 34.8 | 56.4 |
| Days of inventory on hand | 3.4 | 3.8 | 2.9 | 2.8 | 4.9 | 6.1 | 7.3 |
| Days payables outstanding | 34.8 | 43.6 | 36.0 | 19.5 | 20.8 | 22.9 | 44.2 |
| Cash conversion cycle (days) | 14.2 | 8.3 | 13.8 | 22.4 | 23.4 | 18.0 | 19.5 |
| Receivables turnover | 8.02 | 7.57 | 7.76 | 9.32 | 9.29 | 10.48 | 6.47 |
| Payables turnover | 10.49 | 8.36 | 10.13 | 18.68 | 17.56 | 15.93 | 8.25 |
| Inventory turnover | 106.71 | 97.03 | 127.98 | 130.37 | 74.51 | 59.93 | 49.84 |
| Asset turnover | 0.99 | 0.79 | 0.64 | 0.62 | 0.74 | 1.70 | 1.04 |
| Average receivables | $85.7M | $72.0M | $59.7M | $40.9M | $23.5M | $13.5M | $12.4M |
| Average payables | $39.8M | $39.5M | $28.2M | $12.6M | $9.2M | $6.8M | $7.9M |
| Average inventory | $3.9M | $3.4M | $2.2M | $1.8M | $2.2M | $1.8M | $1.3M |
| Intangibles / total assets | 41.5% | 43.3% | 42.2% | 40.5% | 59.0% | 3.0% | 6.1% |
Computed from XMTR's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
XMTR valuation and financial ratios
Xometry earned a return on equity of −20.9% and a return on invested capital of −9.3% in fiscal 2025. It ended the year with $349.3 million of debt and $219.1 million in cash and short-term investments, net debt of $130.1 million. It returned $8.1 million to shareholders: $0 in dividends and $8.1 million in share buybacks. The share count rose 14.6% from 44.3M to 50.8M over 6 years.
See the XMTR income statement, the XMTR chart for price history, or the XMTR stock overview for the latest quote and news.
XMTR key metrics FAQ
What is Xometry's return on equity?
Xometry's return on equity (ROE) was −20.9% in fiscal 2025: net income of -$61.8 million on average shareholders' equity of $295.0 million.
What is Xometry's ROIC?
Xometry's return on invested capital was −9.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Xometry have?
Xometry had total debt of $349.3 million at the end of fiscal 2025, a debt-to-equity ratio of 1.27.
Does Xometry buy back its shares?
Yes. Xometry spent $8.1 million on net share repurchases in fiscal 2025 Shares outstanding changed +3.5% over the year, to 50.8M..
What is Xometry's free cash flow yield?
Xometry generated -$24.1 million of free cash flow in fiscal 2025, a free cash flow yield of −0.8% on its market value at year-end ($3.0 billion).
What is Xometry's current ratio?
Xometry's current ratio was 3.76 at the end of fiscal 2025: current assets were 3.76 times current liabilities.